Roberto Pellicciari
Bridge Pharma (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Neuroscience and Neuropharmacology Research, Chemical Synthesis and Analysis, Cyclopropane Reaction Mechanisms, PARP inhibition in cancer therapy
Most-Cited Works
- → TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis(2009)1,757 cited
- → Targeting bile-acid signalling for metabolic diseases(2008)1,372 cited
- → 6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity(2002)725 cited
- → TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading(2011)563 cited
- → Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities(2002)554 cited
- → The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis(2004)457 cited